Cartesian Therapeutics Inc (RNAC)

Financing Cash Flow

$34.67M

Quarterly · Period ending: · USD

RNAC logo

RNAC Financing Cash Flow

Latest reported$34.67M
RNAC Quarterly Cash from Financing (-$207.00K → $34.67M)
High-resolution chart · PNG

RNAC financing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Cartesian Therapeutics Inc Financing Cash Flow — Quarterly (USD)
Period endingFinancing Cash Flow (USD)
34,673,000
15,671,000
-52,000
-38,000
60,000
-8,025,000
783,000
124,494,000
120,000
43,031,000
14,081,000
-24,789,000
-2,586,000
149,000
0
612,000
36,875,000
1,728,000
21,156,000
1,450,000
8,984,000
21,307,000
-190,000
20,948,000
-957,000
-5,370,000
68,534,000
5,028,000
372,000
31,107,000
80,000
255,000
311,000
51,000
5,038,000
7,331,000
53,946,000
-292,000
2,792,000
2,359,000
64,185,000
-1,677,000
5,686,000
31,985,000
6,442,000
-207,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.